1. Protection against murine intestinal amoebiasis induced by oral immunization with the 29 kDa antigen of Entamoeba histolytica and cholera toxin.
- Author
-
Carrero JC, Contreras-Rojas A, Sánchez-Hernández B, Petrosyan P, Bobes RJ, Ortiz-Ortiz L, and Laclette JP
- Subjects
- Administration, Oral, Animals, Antibodies, Protozoan biosynthesis, Antibodies, Protozoan blood, Antigens, Protozoan administration & dosage, Antigens, Surface administration & dosage, Cecum parasitology, Cecum pathology, Cholera Toxin administration & dosage, Cricetinae, Disease Models, Animal, Germ-Free Life, Humans, Immunization methods, Immunoglobulin A, Secretory biosynthesis, Immunoglobulin A, Secretory blood, Immunoglobulin G biosynthesis, Immunoglobulin G blood, Mice, Mice, Inbred C3H, Recombinant Fusion Proteins immunology, Recombinant Proteins administration & dosage, Antigens, Protozoan immunology, Antigens, Surface immunology, Cholera Toxin immunology, Dysentery, Amebic prevention & control, Entamoeba histolytica immunology, Recombinant Proteins immunology
- Abstract
Entamoeba histolytica antigens recognized by salivary IgA from infected patients include the 29 kDa antigen (Eh29), an alkyl hydroperoxide reductase. Here, we investigate the potential of recombinant Eh29 and an Eh29-cholera toxin subunit B (CTxB) fusion protein to confer protection against intestinal amoebiasis after oral immunization. The purified Eh29-CTxB fusion retained the critical ability to bind ganglioside GM(1), as determined by ELISA. Oral immunization of C3H/HeJ mice with Eh29 administered in combination with a subclinical dose of whole cholera toxin, but not as an Eh29-CTxB fusion, induced elevated levels of intestinal IgA and serum IgG anti-Eh29 antibodies that inhibited trophozoites adherence to MDCK cell monolayers. The 80% of immunized mice seen to develop IgA and IgG immune responses showed no evidence of infection in tissue sections harvested following intracecal challenge with virulent E. histolytica trophozoites. These results suggest that Eh29 is capable of inducing protective anti-amoebic immune responses in mice following oral immunization and could be used in the development of oral vaccines against amoebiasis., ((c) 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF